文献速递多重用药老年慢病共病管理

多重用药与死亡率的关联:基础疾病混杂的影响

Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity.
PubMed 文献 · J Am Geriatr Soc · 2025-07-04

该研究利用丹麦全国登记数据,分析疗养院居民(n=95,057)和社区居住≥65岁人群(n=1,005,963)中多重用药与1年死亡率的关联。调整年龄、性别和合并症后,疗养院队列的比值比从4.70降至2.23,社区队列从10.39降至1.34,表明适应症混杂强烈影响该关联。

要点

  • 多重用药与死亡率的关联在调整合并症后大幅减弱,提示适应症混杂是主要驱动因素。
  • 疗养院居民用药数量随时间波动较大,而社区人群个体用药相对稳定。
  • 部分药物类别(如抗痴呆药)与死亡率呈 paradoxical 负相关,提示残余混杂可能。

核心结论

  • 多重用药水平与死亡率的关联受适应症混杂强烈影响,基础调整合并症后关联减弱但未完全消除,残余关联可能由残余混杂驱动。

研究设计与样本

  • 基于登记数据的全国性研究,纳入2015-2021年入住疗养院的全部丹麦公民(n=95,057)和社区居住≥65岁人群队列(n=1,005,963)。
  • 使用Kaplan-Meier图分析1年死亡率,并采用限制性立方样条模型在不同调整水平下建模用药数量与死亡的关联。

主要发现

  • 疗养院队列中,用药数量与死亡率呈近似线性增加,调整性别、年龄和合并症后比值比从4.70(95%CI:4.24-5.21)降至2.23(95%CI:1.99-2.49)。
  • 社区居住队列中,调整协变量对关联影响更大,比值比从10.39(95%CI:9.79-11.03)降至1.34(95%CI:1.25-1.43)。
  • 部分药物类别呈现 paradoxical 关联,如抗痴呆药与死亡率呈强负相关。
  • 疗养院居民个体用药数量随时间波动较大,而社区人群个体用药相对稳定。

临床怎么用

  • 解读多重用药与死亡率的研究结果时需谨慎,应充分考虑基础疾病等适应症混杂的影响。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies consistently associate use of multiple medications with increased mortality. However, such studies often lack adequate adjustment for confounding, particularly from underlying diseases. OBJECTIVE: To illustrate challenges in studying the association between polypharmacy and mortality by examining this relationship in two separate populations. METHODS: A register-based nationwide study utilizing a cohort of all Danish citizens admitted to nursing homes 2015-2021 (n = 95,057) and a community dwelling population cohort aged ≥ 65 years (n = 1,005,963). We examined the 1-year mortality using a Kaplan Meier plot from date of nursing home admission or index date and modeled the association between the number of medications used and death using restricted cubic splines with varying levels of adjustment. Further, we modeled the association between the 20 most used drugs and 1-year mortality. RESULTS: In the nursing home cohort, we found an approximately linear increase in mortality with the number of medications used. Adjusting for sex, age, and comorbidities markedly attenuated the association from an odds ratio of 4.70 (95% CI: 4.24-5.21) to 2.23 (95% CI: 1.99-2.49). Paradoxical associations were observed for individual drug classes, such as antidementia drugs showing a strong inverse association with mortality. When examining the stability of the number of drugs used over time, we found considerable fluctuations for individual residents. In the community dwelling population cohort, adjustment for covariates showed an even stronger impact on the association, reducing the odds ratio from 10.39 (95% CI: 9.79-11.03) to 1.34 (95% CI: 1.25-1.43). Further, the individual-level use of medication was found to be stable over time in the general population. CONCLUSION: The association between levels of polypharmacy and mortality is strongly affected by confounding by indication. Basic adjustment for comorbidities attenuates but does not fully eliminate the association, with residual association possibly driven by residual confounding. This emphasizes the need for cautious interpretation of findings associating high use of medication with mortality.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Bjørk E, Rentsch CT, Desai RJ, et al. Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity. J Am Geriatr Soc. 2025. PMID: 40614131. doi:10.1111/jgs.19572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。